Summary
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The report forecast global Pimozide market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025.
The report offers detailed coverage of Pimozide industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pimozide by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Pimozide market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Oceania], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Pimozide according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Pimozide company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:

Market Overview

, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Geography
Part 3-4:
Asia-Pacific Market by Type, Application & Geography
Part 5-6:
Europe Market by Type, Application & Geography
Part 7-8:
North America Market by Type, Application & Geography
Part 9-10:
South America Market by Type, Application & Geography
Part 11-12:
Middle East & Africa Market by Type, Application & Geography
Part 13:
Company information, Sales, Cost, Margin etc.
Part 14:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Oceania]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Market by Type
1Mg
2Mg
4Mg
Market by Application
Hospitals
Drugstores
Others